Public Pension Capital Invests in Life Science Outsourcing, Inc.
January 25, 2021
Public Pension Capital, a New York-based private equity fund, made an investment in Life Science Outsourcing, Inc., a Brea, California-based contract manufacturer serving medical device companies. The transaction, completed January 25, 2021, will support LSO's medical package testing, validation, sterilization and distribution services and help accelerate the company's growth and capacity to serve device startups and larger OEMs.
- Buyers
- Public Pension Capital
- Targets
- Life Science Outsourcing, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Oakley Capital Invests in ProductLife Group
May 28, 2024
Pharmaceuticals
Oakley Capital Fund V is investing in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the life sciences industry. Oakley will partner with management and reinvesting shareholder 21 Invest to support international expansion, accelerate AI-driven technology enablement, and pursue a buy-and-build strategy.
-
Life Science Outsourcing Acquires J-Pac Medical
January 5, 2023
Medical Devices
Life Science Outsourcing, Inc. (LSO), a PE-backed contract manufacturer headquartered in Brea, California, has acquired J-Pac Medical, a Somersworth, New Hampshire-based medical device and diagnostics contract manufacturer. The acquisition expands LSO's capabilities into biomaterials, reagent blister packaging, thermoforming and sterilization, broadening its service offering and East Coast and Costa Rica production footprint.
-
EQT Acquires LSP (Life Sciences Partners)
November 10, 2021
Financial Services
EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.
-
Sier Capital Partners and ILS Management Complete Management Buyout of Integrated Laboratory Systems (ILS)
September 14, 2020
Healthcare Services
Sier Capital Partners is supporting the management team of Integrated Laboratory Systems (ILS) in an acquisition of the company. ILS, a Research Triangle Park, North Carolina–based contract research organization that provides pre-clinical toxicology and product safety testing, will leverage Sier’s capital and operating expertise to support future growth.
-
21 Invest France Acquires ProductLife Group
January 21, 2019
Healthcare Services
21 Invest France has acquired ProductLife Group, a regulatory affairs and pharmacovigilance outsourcing specialist serving pharmaceutical, biotech and medical device clients. The investment will support ProductLife’s international expansion and accelerate growth through external acquisitions, innovation and new service launches.
-
Thompson Street Capital Partners Acquires LifeSpan Biosciences (LSBio)
September 17, 2018
Biotechnology
Thompson Street Capital Partners (TSCP), a St. Louis-based private equity firm, has partnered with management to acquire Seattle-based LifeSpan Biosciences, Inc. (LSBio), a developer and e‑commerce distributor of antibodies, kits, proteins and related reagents for academic and pharmaceutical research. TSCP said it will support LSBio's strategy to expand its catalog and capabilities organically and via targeted acquisitions; terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.